Patent details
EP2906298 Title: PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2906298
- WO Application Number:
- EP2013071346
- Type:
- European Patent Granted for NL
- Status:
- Patent in Force
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP13785831.2
- WO Publication Number:
- WO2014057117
- EPO Publication Language:
- English
- SPC Number:
-
301231
- First Applicant Residence Country:
- Switzerland (CH)
- Publications:
Dates
- Filing date:
- 11/10/2013
- Grant date:
- 03/10/2018
- EP Publication Date:
- 19/08/2015
- WO Publication Date:
- 17/04/2014
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 05/12/2018
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 03/10/2018
- EP B1 Publication Date:
- 03/10/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 10/10/2033
- Lapsed By Expiration Date:
- Patent Validated Date:
- 22/12/2018
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 27/09/2022
- Name:
- ADC Therapeutics SA
- Address:
- Biopôle Route de la Corniche 3B, 1066, Epalinges, Switzerland (CH)
- From:
- 03/10/2018
- Name:
- Medimmune Limited
- Address:
- Milstein Building Granta Park, CAMBRIDGE, CAMBRIDGESHIRE CB21 6GH, United Kingdom (GB)
Historical Applicant/holder
- From:
- 03/10/2018
- To:
- 27/09/2022
- Name:
- ADC Therapeutics SA
- Address:
- Route de la Corniche 3B, 1066 Epalinges, Switzerland (CH)
Agent
- Name:
- ir. M.F.J.M. Ketelaars c.s.
- From:
- 21/12/2018
- Address:
- NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
- To:
Inventor
1
- Name:
- VAN BERKEL, Patricius Hendrikus Cornelis
- Address:
- 1003 Lausanne, Switzerland (CH)
2
- Name:
- HOWARD, Philip Wilson
- Address:
- London Greater London E1 2AX, United Kingdom (GB)
Pledgee
- Name:
- Owl Rock Opportunistic Master Fund I, L.P.
- Address:
- 399 Park Avenue, 38th FL, 10022, New York, NY, United States of America (US)
Priority
1
- Priority Patent Number:
- 201361784383 P
- Priority Date:
- 14/03/2013
- Priority Country:
- United States of America (US)
2
- Priority Patent Number:
- 201361784362 P
- Priority Date:
- 14/03/2013
- Priority Country:
- United States of America (US)
3
- Priority Patent Number:
- 201361784421 P
- Priority Date:
- 14/03/2013
- Priority Country:
- United States of America (US)
4
- Priority Patent Number:
- 201261712928 P
- Priority Date:
- 12/10/2012
- Priority Country:
- United States of America (US)
5
- Priority Patent Number:
- 201261712924 P
- Priority Date:
- 12/10/2012
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61P 35/00; A61P 39/00; A61K 47/68;
Publication
Bulletin
1
- Bulletin Heading:
- MED
- Journal edition number:
- 47/23
- Publication date:
- 22/11/2023
- Description:
- Other communications
2
- Bulletin Heading:
- MED
- Journal edition number:
- 40/22
- Publication date:
- 05/10/2022
- Description:
- Other communications
3
- Bulletin Heading:
- MED
- Journal edition number:
- 29/20
- Publication date:
- 14/08/2020
- Description:
- Other communications
4
- Bulletin Heading:
- EP3
- Journal edition number:
- 53/18
- Publication date:
- 28/12/2018
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
5
- Bulletin Heading:
- EP2
- Journal edition number:
- 41/18
- Publication date:
- 03/10/2018
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
- Issue number:
- 201840
- Publication date:
- 03/10/2018
- Description:
- Grant (B1)
Deed
Right of Pledge
- Change Kind/ Decision Type:
- Removed
- Deed Number:
- RC202302251A
- Date Registered:
- 08/11/2023
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. R.C. van Duijvenbode c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Removed Pledgee(s)
- Name:
- Deerfield Partners, L.P.
- Address:
- 780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Change of Address
- Change Kind/ Decision Type:
- Owner
- Deed Number:
- RC202202466A
- Date Registered:
- 27/09/2022
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. R.C. van Duijvenbode c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Right of Pledge
- Change Kind/ Decision Type:
- Established
- Deed Number:
- RC202202466B
- Date Registered:
- 27/09/2022
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- dr. R.C. van Duijvenbode c.s.
- Journal Edition Number:
- Text:
- Aandeel van ADC Therapeutics SA is verpand aan Owl Rock Opportunistic Master Fund I, L.P.
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Pledgee(s)
- Name:
- Owl Rock Opportunistic Master Fund I, L.P.
- Address:
- 399 Park Avenue, 38th FL, 10022, New York, NY, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Right of Pledge
- Change Kind/ Decision Type:
- Established
- Deed Number:
- RC202001210A
- Date Registered:
- 25/06/2020
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. M.F.J.M. Ketelaars c.s.
- Journal Edition Number:
- Text:
- Het aandeel van ADC Therapeutics SA is verpand.
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Pledgee(s)
- Name:
- Deerfield Partners, L.P.
- Address:
- 780 Third Avenue, 37th Floor, 10017, New York, NY, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/10/2025
- Annual Fee Number:
- 13
- Annual Fee Amount:
- 700 Euro
- Last Annual Payment Date:
- 23/10/2024
- Last Annual Fee Paid Number:
- 12
- Last Annual Fee Paid Amount:
- 600 Euro
- Payer:
- Mewburn Ellis LLP
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 21/12/2018 | Outgoing Correspondence | Letter no formal defects | 1 | /7/5/3/2/2/0800322357/docs/ep13785831.2_0_246377l271.pdf | ||
| 05/12/2018 | Claims | First filed claims | 3 | /7/5/3/2/2/0800322357/docs/ep13785831.2_1_claims20181205154527020.pdf | ||
| 05/12/2018 | Incoming Correspondence Electronic | Accompanying letter incoming document | 2 | /7/5/3/2/2/0800322357/docs/ep13785831.2_2_incomingcorrespondenceelectronic20181205154527941.pdf |